mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |